Yan-Ling He

The Dipeptidyl Peptidase IV Inhibitor Vildagliptin Suppresses Endogenous Glucose Production and Enhances Islet Function after Single-Dose Administration in Type 2 Diabetic Patients

Bogdan Balas, Muhammad R. Baig, Catherine E. Watson et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 242 citations

Medicine, Endocrinology, Pharmacology +17

Measurements of Islet Function and Glucose Metabolism with the Dipeptidyl Peptidase 4 Inhibitor Vildagliptin in Patients with Type 2 Diabetes

Koichiro Azuma, Žofia Rádiková, Juliet Mancino et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 121 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Prescription of antipsychotic and concomitant medications for adult Asian schizophrenia patients: Findings of the 2016 Research on Asian Psychotropic Prescription Patterns (REAP) survey

Min Dong, Liang-Nan Zeng, Qinge Zhang et al. · Asian Journal of Psychiatry · 2019 · 53 citations

Pharmacy, Pharmacotherapy, Psychiatry +16

Clozapine prescription pattern in patients with schizophrenia in Asia: The REAP survey (2016)

Shi-Wei Xu, Min Dong, Qinge Zhang et al. · Psychiatry Research · 2019 · 48 citations

Pharmacy, Pharmacotherapy, Psychiatry +14

Common Use of Antipsychotic Polypharmacy in Older Asian Patients With Schizophrenia (2001–2009)

Yu‐Tao Xiang, Faith Dickerson, Julie Kreyenbuhl et al. · Journal of Clinical Psychopharmacology · 2012 · 30 citations

Pharmacy, Pharmacotherapy, Psychiatry +14